Macrophage-derived macrophage migration inhibitory factor mediates renal injury in anti-glomerular basement membrane glomerulonephritis

被引:0
作者
Yang, Hui [1 ,2 ]
Li, Jinhong [3 ]
Huang, Xiao-ru [2 ,4 ]
Bucala, Richard [5 ]
Xu, Anping [1 ]
Lan, Hui-Yao [2 ,4 ]
机构
[1] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Nephrol, Guangzhou, Peoples R China
[2] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Lui Che Woo Inst Innovat Med, Dept Med & Therapeut, Hong Kong, Peoples R China
[3] SunYat sen Univ, Affiliated Hosp 7, Dept Nephrol, Shenzhen, Peoples R China
[4] Southern Med Univ, Guangdong Prov Hosp, Dept Nephrol & Pathol, Guangzhou, Peoples R China
[5] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT USA
来源
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
关键词
macrophages; MIF; T cells; anti-GBM crescentic glomerulonephritis; inflammation; FACTOR MIF; IMMUNE-RESPONSES; KIDNEY-DISEASE; T-CELLS; EXPRESSION; NEPHRITIS; ANTIBODY; RECEPTOR;
D O I
10.3389/fimmu.2024.1361343
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Macrophages are a rich source of macrophage migration inhibitory factor (MIF). It is well established that macrophages and MIF play a pathogenic role in anti-glomerular basement membrane crescentic glomerulonephritis (anti-GBM CGN). However, whether macrophages mediate anti-GBM CGN via MIF-dependent mechanism remains unexplored, which was investigated in this study by specifically deleting MIF from macrophages in MIFf/f-lysM-cre mice. We found that compared to anti-GBM CGN induced in MIFf/f control mice, conditional ablation of MIF in macrophages significantly suppressed anti-GBM CGN by inhibiting glomerular crescent formation and reducing serum creatinine and proteinuria while improving creatine clearance. Mechanistically, selective MIF depletion in macrophages largely inhibited renal macrophage and T cell recruitment, promoted the polarization of macrophage from M1 towards M2 via the CD74/NF-kappa B/p38MAPK-dependent mechanism. Unexpectedly, selective depletion of macrophage MIF also significantly promoted Treg while inhibiting Th1 and Th17 immune responses. In summary, MIF produced by macrophages plays a pathogenic role in anti-GBM CGN. Targeting macrophage-derived MIF may represent a novel and promising therapeutic approach for the treatment of immune-mediated kidney diseases.
引用
收藏
页数:14
相关论文
共 59 条
  • [1] Averdunk LS, 2017, CIRCULATION, V136
  • [2] MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment
    Bernhagen, Juergen
    Krohn, Regina
    Lue, Hongqi
    Gregory, Julia L.
    Zernecke, Alma
    Koenen, Rory R.
    Dewor, Manfred
    Georgiev, Ivan
    Schober, Andreas
    Leng, Lin
    Kooistra, Teake
    Fingerle-Rowson, Guenter
    Ghezzi, Pietro
    Kleemann, Robert
    McColl, Shaun R.
    Bucala, Richard
    Hickey, Michael J.
    Weber, Christian
    [J]. NATURE MEDICINE, 2007, 13 (05) : 587 - 596
  • [3] Macrophage migration inhibitory Factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus
    Bilsborrow, Joshua B.
    Doherty, Edward
    Tilstam, Pathricia V.
    Bucala, Richard
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2019, 23 (09) : 733 - 744
  • [4] T-CELLS AND MACROPHAGES IN RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS - CLINICOPATHOLOGICAL CORRELATIONS
    BOLTON, WK
    INNES, DJ
    STURGILL, BC
    KAISER, DL
    [J]. KIDNEY INTERNATIONAL, 1987, 32 (06) : 869 - 876
  • [5] Brown FG, 2002, J AM SOC NEPHROL, V13, pS7
  • [6] Elevated Serum Macrophage Migration Inhibitory Factor (MIF) Concentrations in Chronic Kidney Disease (CKD) Are Associated with Markers of Oxidative Stress and Endothelial Activation
    Bruchfeld, Annette
    Carrero, Juan J.
    Qureshi, Abdul R.
    Lindholm, Bengt
    Barany, Peter
    Heimburger, Olof
    Hu, Maowen
    Lin, Xinchun
    Stenvinkel, Peter
    Miller, Edmund J.
    [J]. MOLECULAR MEDICINE, 2009, 15 (3-4) : 70 - 75
  • [7] Macrophage depletion ameliorates nephritis induced by pathogenic antibodies
    Chalmers, Samantha A.
    Chitu, Violeta
    Herlitz, Leal C.
    Sahu, Ranjit
    Stanley, E. Richard
    Putterman, Chaim
    [J]. JOURNAL OF AUTOIMMUNITY, 2015, 57 : 42 - 52
  • [8] M2 macrophages in kidney disease: biology, therapies, and perspectives
    Chen, Titi
    Cao, Qi
    Wang, Yiping
    Harris, David C. H.
    [J]. KIDNEY INTERNATIONAL, 2019, 95 (04) : 760 - 773
  • [9] Evidence for a role of macrophage migration inhibitory factor in vascular disease
    Chen, ZP
    Sakuma, M
    Zago, AC
    Zhang, XB
    Shi, C
    Leng, L
    Mizue, Y
    Bucala, R
    Simon, DI
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (04) : 709 - 714
  • [10] Macrophage Migration Inhibitory Factor Mediates Proliferative GN via CD74
    Djudjaj, Sonja
    Lue, Hongqi
    Rong, Song
    Papasotiriou, Marios
    Klinkhammer, Barbara M.
    Zok, Stephanie
    Klaener, Ole
    Braun, Gerald S.
    Lindenmeyer, Maja T.
    Cohen, Clemens D.
    Bucala, Richard
    Tittel, Andre P.
    Kurts, Christian
    Moeller, Marcus J.
    Floege, Juergen
    Ostendorf, Tammo
    Bernhagen, Juergen
    Boor, Peter
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 27 (06): : 1650 - 1664